Gentex is trading $20.20, down 7.08% in pre-market after reporting third-quarter 2026 results below expectations. - Net sales were $647.7 million and diluted EPS was $0.43; adjusted EPS was $0.47 versus $0.50 consensus, and revenue missed the roughly $670 million estimate. - The release cited about $35 million in revenue shortfalls versus internal forecasts, including customer launch delays and regional headwinds. - Management lowered its full-year 2026 revenue and margin outlooks.